Fighting against Drug-Resistant Tumor by the Induction of Excessive Mitophagy with Transferrin Nanomedicine.

Yu, Yuanxiang; Chen, Sijin; Wang, Yupeng; Zhou, Dongfang; Wu, Dehua

Yu, Yuanxiang; Chen, Sijin; Wang, Yupeng; Zhou, Dongfang; Wu, Dehua.

Afiliación

Yu Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, P. R. China.
Chen S; Department of Radiation Oncology, The Cancer Hospital of Shantou University Medical College, Shantou, 515041, P. R. China.
Wang Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, P. R. China.
Zhou D; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, P. R. China.
Wu D; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, P. R. China.

Macromol Biosci ; 24(2): e2300116, 2024 Feb.

Article en En | MEDLINE | ID: mdl-37677756

Asunto(s)

Nanopartículas; Neoplasias; Humanos; Nanomedicina/métodos; Mitofagia; Transferrina; Doxorrubicina/farmacología

Palabras clave

cancer therapy; excessive mitophagy; multidrug resistance; quercetin; transferrin nanoparticles

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias Límite: Humans Idioma: En Revista: Macromol Biosci Asunto de la revista: BIOQUIMICA Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google